Leafly Holdings, Inc. (LFLY)

ZoomInfo Technologies (NASDAQ: ZI - Get Free Report) and Leafly (OTC: LFLY - Get Free Report) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional and Insider Ownership 95.5% of ZoomInfo

Institutional and Insider Ownership 15.6% of Leafly shares are held by institutional investors. 23.8% of Information Analysis shares are held by insiders. Comparatively, 6.9% of Leafly shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long

Leafly (OTC: LFLY - Get Free Report) and Intellicheck (NYSE: IDN - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Analyst Recommendations This is a summary of current ratings

Leafly (OTC: LFLY - Get Free Report) and Xperi (NASDAQ: XPER - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings. Analyst Recommendations This is a breakdown of recent recommendations

Insider and Institutional Ownership 15.6% of Leafly shares are owned by institutional investors. 27.7% of Intellinetics shares are owned by insiders. Comparatively, 6.9% of Leafly shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Semrush (NASDAQ: SEMR - Get Free Report) and Leafly (OTC: LFLY - Get Free Report) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Profitability This table compares Semrush and Leafly's

Semrush (NASDAQ: SEMR - Get Free Report) and Leafly (OTC: LFLY - Get Free Report) are both small-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends and valuation. Analyst Recommendations This is a breakdown of

Leafly (OTC: LFLY - Get Free Report) and Elys BMG Group (NASDAQ: ELYS - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations and earnings. Valuation and Earnings This table compares Leafly

The U.S. cannabis industry is gaining momentum again, and ancillary stocks are attracting investor attention this week. The legal market generated over $30 billion in sales last year and could exceed $50 billion by 2030. Ancillary companies provide vital tools, marketplaces, and supplies, making them less exposed to direct regulation. Recent headlines highlight renewed discussions in Congress about cannabis banking reform and potential federal rescheduling. Therefore, optimism is building around improved access to capital and market expansion. Investors are closely watching companies that support dispensaries, growers, and consumers with platforms and infrastructure. These businesses often benefit as legalization advances across more states.

The U.S. cannabis industry continues to expand rapidly, making ancillary stocks an attractive area for investors. In 2024, legal cannabis sales reached more than $29 billion nationwide. Analysts project the market could surpass $45 billion by 2030 as legalization spreads. Ancillary companies supply the technology, data, and cultivation tools that dispensaries and growers need to operate efficiently. These businesses avoid direct plant-touching risks while benefiting from industry growth. Recently, headlines surrounding potential federal legalization and banking reform have reignited investor interest. Moreover, new state markets continue to open, driving opportunities for service providers. Therefore, ancillary stocks remain critical watchlist candidates.

The cannabis industry continues expanding rapidly, especially online. Many consumers now rely on digital platforms to explore products and find local dispensaries. At the same time, ancillary sectors like technology, packaging, and paraphernalia have become essential. These businesses do not handle cannabis directly. Instead, they support the market from the sidelines. The U.S. cannabis industry is valued at over $45 billion in 2025. Analysts expect strong growth to continue over the next five years. As demand rises, so does the need for accessories and digital services. Retailers depend on software and secure packaging to stay compliant. Additionally, online traffic helps drive sales and brand visibility. Because of this, ancillary companies remain in focus. They serve critical functions and often face fewer legal risks than growers or dispensaries. Therefore, many investors see them as smart exposure to the cannabis sector.

What is going to happen to marijuana stock and when will the sector bounce? This is the long-standing question and roadblock for many who hold shares of cannabis stocks. With the current political climate in the USA, it is not easy to have strong convictions of positive market outcomes. To further explain it is not that volatile pops can not happen as that is happening now. But with many issues in the way for investors and legal operators, it impacts the public sector in such a way.

The U.S. cannabis industry continues to expand, creating strong opportunities for ancillary companies that support dispensaries and cultivators. In 2024, legal cannabis sales in the U.S. exceeded $35 billion, with projections reaching over $40 billion by 2025. Ancillary businesses that provide technology, equipment, and services benefit from this rapid growth without facing the same legal challenges as plant-touching companies. Recently, federal legalization talks have gained momentum, with lawmakers pushing for banking reform and rescheduling cannabis. If these changes occur, more businesses could enter the market, boosting demand for ancillary services. Investors looking for exposure to the sector should watch these stocks closely.

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Leafly Holdings Inc ("LFLY" or the "Company") (NASDAQ:LFLY) stock purchased prior to January 28, 2022. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Merida Merger Corp. I, and whether the Board of Leafly Holdings harmed stockholders, and whether all material facts had been properly disclosed to stockholders.